Frank Baas Selected Research

CADASIL

10/2022	Effect of NOTCH3 EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes.
1/2020	Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frank Baas Research Topics

Disease

11	Neoplasms (Cancer) 08/2017 - 04/2002
8	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2017 - 10/2011
7	Pontocerebellar Hypoplasia 01/2021 - 09/2008
7	Alzheimer Disease (Alzheimer's Disease) 09/2008 - 03/2004
4	Neuroinflammatory Diseases 01/2023 - 01/2018
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2018 - 12/2007
4	Inflammation (Inflammations) 11/2017 - 06/2009
4	Infections 01/2017 - 04/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2016 - 01/2012
4	Bacterial Meningitis 03/2013 - 10/2011
3	Stroke (Strokes) 01/2023 - 01/2020
3	Wounds and Injuries (Trauma) 05/2022 - 07/2007
3	Atrophy 01/2018 - 11/2014
3	Multiple Sclerosis 01/2017 - 01/2012
3	Dystonia (Limb Dystonia) 07/2014 - 10/2010
3	Pneumococcal Infections 06/2014 - 10/2011
3	Schizophrenia (Dementia Praecox) 07/2011 - 04/2007
3	Medulloblastoma 07/2008 - 03/2002
3	Crush Injuries 04/2008 - 02/2004
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2023 - 01/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 03/2014
2	Disease Progression 01/2023 - 01/2022
2	Gliosis 01/2023 - 01/2023
2	Vascular Diseases (Vascular Disease) 01/2023 - 08/2009
2	Obesity 01/2023 - 01/2023
2	CADASIL 10/2022 - 01/2020
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2021 - 02/2003
2	Dementia (Dementias) 01/2020 - 04/2006
2	Rheumatoid Arthritis 10/2019 - 11/2017
2	Brain Diseases (Brain Disorder) 12/2018 - 10/2016
2	Microcephaly 12/2018 - 10/2016
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 01/2012
2	Pontocerebellar Hypoplasia Type 6 01/2017 - 01/2011
2	Leprosy (Hansen's Disease) 01/2017 - 05/2015
2	Seizures (Absence Seizure) 10/2016 - 11/2014
2	Intellectual Disability (Idiocy) 10/2016 - 11/2014
2	Immunoglobulin G4-Related Disease 01/2016 - 06/2013
2	Cholangitis 01/2016 - 06/2013
2	Muscular Diseases (Myopathy) 09/2015 - 11/2002
2	Myoclonic dystonia 02/2015 - 04/2011
2	Neurilemmoma (Schwannoma) 09/2014 - 04/2007
2	Schwannomatosis 09/2014 - 02/2012
2	Asthma (Bronchial Asthma) 09/2013 - 05/2013
2	Torticollis (Wryneck) 03/2013 - 05/2012
2	22q11 Deletion Syndrome 09/2011 - 07/2011
2	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 06/2010 - 12/2007
2	Amyloid Plaque 02/2010 - 04/2006
2	Peripheral Nerve Injuries 12/2009 - 05/2009
2	Wallerian Degeneration 05/2009 - 07/2007
2	Barth Syndrome 05/2004 - 11/2002
2	Neutropenia 05/2004 - 11/2002
1	Retinal Degeneration 12/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Brain Injuries (Brain Injury) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
18	Complement System Proteins (Complement)IBA 01/2023 - 02/2004
5	splicing endonucleaseIBA 01/2021 - 09/2008
5	RNA (Ribonucleic Acid)IBA 01/2016 - 04/2008
5	Dopamine (Intropin)FDA LinkGeneric 07/2014 - 01/2008
4	Complement C5 (Complement 5)IBA 01/2023 - 10/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2005
4	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2018 - 07/2007
4	RNA Polymerase II (RNA Polymerase B)IBA 12/2005 - 04/2002
3	Antisense OligonucleotidesIBA 01/2023 - 04/2002
3	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2017 - 01/2013
3	Codon (Codons)IBA 12/2016 - 02/2010
3	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 06/2009
3	Small Interfering RNA (siRNA)IBA 07/2010 - 03/2007
3	locked nucleic acidIBA 07/2010 - 02/2003
2	Retinaldehyde (Retinal)IBA 12/2023 - 01/2017
2	Eukaryotic Initiation Factor-2 (EIF 2)IBA 01/2023 - 01/2019
2	Neutralizing AntibodiesIBA 01/2023 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2016
2	Coenzyme A (CoA)IBA 12/2018 - 09/2014
2	EnzymesIBA 12/2018 - 01/2002
2	ChromatinIBA 10/2018 - 02/2012
2	Anaphylatoxin C5a ReceptorIBA 01/2018 - 10/2011
2	AutoantibodiesIBA 11/2017 - 02/2003
2	Monoclonal AntibodiesIBA 01/2017 - 10/2011
2	Complement C3 (C3 Complement)IBA 01/2017 - 03/2013
2	lipoarabinomannan (LAM)IBA 01/2017 - 05/2015
2	Serine Proteases (Serine Protease)IBA 01/2017 - 01/2017
2	CytokinesIBA 01/2017 - 01/2016
2	Arginine-tRNA LigaseIBA 01/2017 - 07/2011
2	Immunoglobulin G (IgG)IBA 01/2016 - 02/2003
2	Oxidoreductases (Dehydrogenase)IBA 09/2014 - 07/2002
2	SteroidsIBA 09/2013 - 05/2013
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2011 - 01/2008
2	Nucleic AcidsIBA 07/2010 - 03/2007
2	Myelin ProteinsIBA 06/2010 - 04/2005
2	Sarcoglycans (beta Sarcoglycan)IBA 10/2008 - 04/2008
2	Amyloid beta-PeptidesIBA 09/2008 - 10/2007
2	Peptides (Polypeptides)IBA 09/2008 - 10/2007
1	Complement C6 (Complement 6)IBA 01/2023
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2023

Therapy/Procedure

12	Therapeutics 01/2023 - 03/2002
1	Foot Orthoses 01/2023